Treatment patterns, duration and outcomes of pemetrexed maintenance therapy in patients with advanced NSCLC in a real-world setting.
CONCLUSION: Real-world effectiveness of pemetrexed maintenance therapy is similar to that observed in published randomized controlled trials, confirming a role for pemetrexed maintenance in eligible patients in clinical practice.
PMID: 30421624 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Alimta | Avastin | Cancer | Cancer & Oncology | Electronic Health Records (EHR) | Lung Cancer | Non-Small Cell Lung Cancer | Research | Statistics | Study | USA Health